2020 Zhejiang Export Commodity Online Fair “Russia – API session” is now launched!

19.10.2020 18:07

The 2020 Zhejiang Export Commodity Online Fair (Pharma Sector) is coming with a new session. The portals for the “Russia – API session” is now launched to welcome the participation of both pharmaceutical suppliers located in Zhejiang Province of China, as well as Russian buyers online.

2020 Zhejiang Export Commodity Online Fair “Russia – API session” is now launched!

Jointly held by Zhejiang Department of Commerce and Shanghai Sinoexpo Informa Markets International Exhibition (PharmaSources.com), the 2020 Zhejiang Export Commodity Online Fair is to facilitate ongoing and new business connections between Zhejiang and Russia pharma markets, filling the production gaps at this challenging time of travel restrictions.

During the Online Fair, pharmaceutical companies will enjoy one-to-one matchmaking service of video meeting and negotiate with their potential partners online through the “Cloud Meeting” function. The new launched online fair will last for 9 days until 23thOct. and is free of charge to all pharmaceutical buyers from Russia.

The Japan & South Korea – API session in August has exhibited nearly 800 products and driven 160 buyers to close deals. The Pakistan – API session held in July has successfully accomplished with over 350 matchmakings between 50 Zhejiang pharmaceutical companies and more than 100 buyers from Pakistan. Earlier, from May 18th to June 12th, the 10 sessions focusing on quality API, intermediates, pharma machinery and fine chemicals products provided by over 80 Zhejiang pharmaceutical suppliers each, has attracted more than 200 buyers who submitted sourcing requests, enjoyed matchmaking services under the help of professional customer service of PharmaSources.com. Meanwhile, the participants have successfully got connected with buyers and suppliers through the online matchmaking system – China Pharma Connect, each supplier or buyer has 20 chances to send invitations to the business partners after browsing and searching for a “right” company.

Zhejiang Export Commodity Online Fair (Pharma Sector) provides a great online platform for buyers depending on its strong database to extend connection and explore opportunities to network and trade with pharma enterprises. Genuinely, we are all here to serve the whole pharmaceutical industry!

LIVE Now Zhejiang Export Commodity Online Fair Link
19-27 Oct
Russia - API

Features Introduction 


·       Digital Marketplace

Nearly 400 Suppliers from Zhejiang China will be displayed online, covering APIs, pharma manufacturing and packaging machinery, pharma intermediates and fine chemicals products. Buyers can select and explore detailed supplier profiles & products online.


·       Matchmaking

China Pharma Connect is the online matchmaking system enables suppliers and buyers to browse and search potential business partners and products, send invitations and get connected online.


·       EZSourcing

Popular products and the purchasing requirements will be posted online until 30 June 2020. Buyers can submit purchasing demand and request for quotations.


·       Cloud Meeting

The Cloud Meeting service enables suppliers and buyers to enjoy convenient “screen to screen” meeting with each other. Buyers can sign up and submit specific purchasing products requirement and access personalized matchmaking services to make appointments and attend one-on-one video meeting for business negotiation.  Sign Up Now: https://jinshuju.net/f/eFVlj2


– Connect with nearly 400 Zhejiang pharmaceutical suppliers online

– Explore detailed supplier profiles & products in the digital showroom

– Post purchasing requests and get multiple quotations

– Sign up as a buyer to enjoy one-on-one video meeting for business negotiation


About PharmaSources.com


Rolled out in 2010 as an online trade platform serving the pharmaceutical industry, PharmaSources has been re-named and rebranded from CPhI.CN in 2020. PharmaSources connects global pharma buyers and suppliers and promotes trade and development across the pharmaceutical industry.